CAS NO: | 2130958-55-1 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Alflutinib (Furmonertinib) mesylate is is a potent inhibitor ofEGFR. Alflutinib (Furmonertinib) mesylate inhibitsEGFRactive mutations as well as the T790M acquired resistant mutation. Alflutinib (Furmonertinib) mesylate has the potential for the research ofcancerdiseases, especially non-small cell lungcancer(NSCLC)[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Alflutinib (Furmonertinib) mesylate is designed to inhibit EGFR active mutations as well as the T790M acquired resistant mutation[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 664.70 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C29H35F3N8O5S | ||||||||||||||||
CAS 号 | 2130958-55-1 | ||||||||||||||||
中文名称 | 甲磺酸伏美替尼;甲磺酸艾氟替尼 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *该产品在溶液状态不稳定,建议您现用现配,即刻使用。 | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 5 mg/mL(7.52 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|